6:17 PM
 | 
Jun 27, 2013
 |  BC Extra  |  Financial News

Heptares secures $21 million in series B

Heptares Therapeutics Ltd. (Welwyn Garden City, U.K.) secured $21 million in a tranched series B round co-led by new investor Stanley Family Foundation and existing...

Read the full 106 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >